Concepedia

Author

Timo Gemoll

University of LübeckORCID

Also Known As

Gemoll, T., Gemoll, Timo, Marc Ehlers, Rickmer Braren, S. Szymczak, T Gemoll, T. Gemoll, T.G. Gemoll, Timo Gemoll

109

Publications

1K

Citations

20

H-Index

38

Concepts

All Affiliations

University of LübeckUniversity Hospital Schleswig-HolsteinKarolinska InstitutetCenter for Cancer ResearchNational Cancer Institute
TG

About

Timo Gemoll is an author at University of Lübeck specializing in medicine, cell biology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

121

2

Engineering

1

1

11

3

Health Sciences

1

1

19

4

Biochemistry

1

1

15

5

Biomedical Engineering

1

1

11

Timo Gemoll

×

26

Publications

697

Citations

17

H-Index

YearCitations

PD-L1 is expressed on human platelets and is affected by immune checkpoint therapy

Verena Rolfes, Christian Idel, Ralph Pries,

Oncotarget

2018

79

IgG Fc sialylation is regulated during the germinal center reaction following immunization with different adjuvants

Yannic C. Bartsch, Simon Eschweiler, Alexei Leliavski,

Journal of Allergy and Clinical Immunology

2020

62

Increased cathepsin D protein expression is a biomarker for osteosarcomas, pulmonary metastases and other bone malignancies

Timo Gemoll, Franziska Epping, Lisa Heinrich,

Oncotarget

2015

56

A novel multiplex-protein array for serum diagnostics of colon cancer: a case–control study

Stefanie Bünger, Ulrike Haug, Maria D. Kelly,

BMC Cancer

2012

42

Single Chromosome Aneuploidy Induces Genome-Wide Perturbation of Nuclear Organization and Gene Expression

Rüdiger Braun, Scott Ronquist, Darawalee Wangsa,

Neoplasia

2019

39

Impact of genomic stability on protein expression in endometrioid endometrial cancer

Marta Lomnytska, Susanne Becker, Timo Gemoll,

British Journal of Cancer

2012

35

MALDI-imaging reveals thymosin beta-4 as an independent prognostic marker for colorectal cancer

Timo Gemoll, Sarah Strohkamp, Katharina Schillo,

Oncotarget

2015

35

The impact of CBP expression in estrogen receptor-positive breast cancer

Wafaa S. Ramadan, Iman M. Talaat, Mahmood Yaseen Hachim,

Clinical Epigenetics

2021

35

<i>HLJ1</i> ( <i>DNAJB4</i> ) Gene Is a Novel Biomarker Candidate in Breast Cancer

Tolga Acun, Natalie Doberstein, Jens K. Habermann,

OMICS A Journal of Integrative Biology

2017

32

Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasis

Lucy Kappes, Ruba L. Amer, Sabine Sommerlatte,

Scientific Reports

2020

32

Page 1